Computational method for estimating DNA copy numbers in normal samples, cancer cell lines, and solid tumors using array comparative genomic hybridization
- PMID: 20706610
- PMCID: PMC2914423
- DOI: 10.1155/2010/386870
Computational method for estimating DNA copy numbers in normal samples, cancer cell lines, and solid tumors using array comparative genomic hybridization
Abstract
Genomic copy number variations are a typical feature of cancer. These variations may influence cancer outcomes as well as effectiveness of treatment. There are many computational methods developed to detect regions with deletions and amplifications without estimating actual copy numbers (CN) in these regions. We have developed a computational method capable of detecting regions with deletions and amplifications as well as estimating actual copy numbers in these regions. The method is based on determining how signal intensity from different probes is related to CN, taking into account changes in the total genome size, and incorporating into analysis contamination of the solid tumors with benign tissue. Hidden Markov Model is used to obtain the most likely CN solution. The method has been implemented for Affymetrix 500K GeneChip arrays and Agilent 244K oligonucleotide arrays. The results of CN analysis for normal cell lines, cancer cell lines, and tumor samples are presented. The method is capable of detecting copy number alterations in tumor samples with up to 80% contamination with benign tissue. Analysis of 178 cancer cell lines reveals multiple regions of common homozygous deletions and strong amplifications encompassing known tumor suppressor genes and oncogenes as well as novel cancer related genes.
Figures
Similar articles
-
The use of ultra-dense array CGH analysis for the discovery of micro-copy number alterations and gene fusions in the cancer genome.BMC Med Genomics. 2011 Jan 27;4:16. doi: 10.1186/1755-8794-4-16. BMC Med Genomics. 2011. PMID: 21272361 Free PMC article.
-
Homozygous deletions and recurrent amplifications implicate new genes involved in prostate cancer.Neoplasia. 2008 Aug;10(8):897-907. doi: 10.1593/neo.08428. Neoplasia. 2008. PMID: 18670647 Free PMC article.
-
A continuous-index hidden Markov jump process for modeling DNA copy number data.Biostatistics. 2009 Oct;10(4):773-8. doi: 10.1093/biostatistics/kxp030. Epub 2009 Jul 23. Biostatistics. 2009. PMID: 19628640
-
Genome-wide analysis of pancreatic cancer using microarray-based techniques.Pancreatology. 2009;9(1-2):13-24. doi: 10.1159/000178871. Epub 2008 Dec 12. Pancreatology. 2009. PMID: 19077451 Review.
-
A survey of analysis software for array-comparative genomic hybridisation studies to detect copy number variation.Hum Genomics. 2010 Aug;4(6):421-7. doi: 10.1186/1479-7364-4-6-421. Hum Genomics. 2010. PMID: 20846932 Free PMC article. Review.
Cited by
-
Challenges in identifying candidate amplification targets in human cancers: chromosome 8q21 as a case study.Genes Cancer. 2012 Feb;3(2):87-101. doi: 10.1177/1947601912456287. Genes Cancer. 2012. PMID: 23050042 Free PMC article.
-
Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer.Clin Cancer Res. 2023 Nov 1;29(21):4419-4429. doi: 10.1158/1078-0432.CCR-23-0898. Clin Cancer Res. 2023. PMID: 37756555 Free PMC article.
-
Cyclin G1 regulates the outcome of taxane-induced mitotic checkpoint arrest.Oncogene. 2012 May 10;31(19):2450-60. doi: 10.1038/onc.2011.431. Epub 2011 Nov 7. Oncogene. 2012. PMID: 22056875 Free PMC article.
References
-
- Friend SH, Bernards R, Rogelj S, et al. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature . 1986;323(6089):643–646. . - PubMed
-
- Kamb A, Gruis NA, Weaver-Feldhaus J, et al. A cell cycle regulator potentially involved in genesis of many tumor types. Science . 1994;264(5157):436–440 . . - PubMed
-
- Steck PA, Pershouse MA, Jasser SA, et al. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nature Genetics . 1997;15(4):356–362. . - PubMed
-
- Little CD, Nau MM, Carney DN, Minna JD. Amplification and expression of the c-myc oncogene in human lung cancer cell lines. Nature . 1983;306(5939):194–196. . - PubMed
-
- Lin CR, Chen WS, Kruiger W, et al. Expression cloning of human EGF receptor complementary DNA: gene amplification and three related messenger RNA products in A431 cells. Science . 1984;224(4651):843–848. . - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources